Diamir, LLC

Princeton, NJ 08540

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $2.84MM
First Award Date 07/01/13
Most Recent Award Date 03/01/17

Key Personnel

Last Name Name Awards Contact
Umansky Samuil R Umansky 5

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-091
Budget: 03/01/17 - 02/28/18

SUMMARY About 10-20% of Americans age 65+ have Mild Cognitive Impairment (MCI), of which ~15% progress to dementia annually. A growing number of companies are developing new therapeutics aiming to intervene early in the development of Alzheimer's disease, the most common form of dementia, and there is a great need for accurate, minimally invasiv...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 06/01/16 - 11/30/16

? DESCRIPTION (provided by applicant): A number of academic groups and life sciences companies are developing and testing approaches to delay aging -- the most significant risk factor for the vast majority of serious human diseases. Critical for these efforts is the development and validation of minimally invasive, cost-effective biomarkers of...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 02/01/16 - 01/31/17

DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is the most common neurodegenerative disease (ND). Currently in the US there are 5.4M AD patients; associated healthcare cost is $200B per year. 10-20% of people age 65+ have Mild Cognitive Impairment (MCI) of which estimated 15% progress to dementia annually. Although no disease- mod...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 02/15/15 - 01/31/16

DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is the most common neurodegenerative disease (ND). Currently in the US there are 5.4M AD patients;associated healthcare cost is $200B per year. 10-20% of people age 65+ have Mild Cognitive Impairment (MCI) of which estimated 15% progress to dementia annually. Although no disease- modi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 07/01/13 - 12/31/13

DESCRIPTION (provided by applicant): Alzheimer's Disease (AD) is the most common neurodegenerative disease: 5.4 million people are currently living with AD in the US, and up to 80 million Americans (over 55 years old) are considered to constitute the risk group for AD. In 2011, the annual cost of healthcare services for AD patients in the US rea...